Catalyst / setup – Gapped down 26% on Brazil elections, doing an Xray on FinViz showed a strong company looking for overdone bounce using 5m ROE, entered just before Brazilian stock market open expecting big move either way.
Result – Scaled 50% at 13:12 @ 11.61 , scaled another 50% at 13:14 @ 11.72, runner still running
Fridays market: Money leaving the market – Normal selling pressure
TC2000 McClellan: 46
Stocks above 40PMA T2108: 39
VIX: 19
52 week highs (US common stocks): 231
Seasonality:The historical case: October is the midterm year’s best month
Since 1950, October has been the best-performing month in U.S. midterm years, averaging a 3% gain for the S&P 500 and posting positive returns 73.7% of the time. November ranks second, averaging a 2.7% gain, with positive returns 78.9% of the time. The midterm effect is large. Across all years, October has been positive nearly 60% of the time since 1950, with an average gain of 0.89%, so the midterm version roughly triples the typical October return. LPL also notes that the improvement from October onwards in midterm years has not depended on which party holds the Presidency.
The key difference from the template.
The midterm Q4 rally has historically started from a deep autumn low, which you’ve already noted. Since 1950, the S&P 500 has suffered an average peak-to-trough decline of about 18% in midterm years. In 2026, the S&P 500 fell 5% in the first quarter, rallied 15% in the second, and gained 2% in the third, and it remains less than 2% below its last record close. The early-year weakness fits the pattern. But there hasn’t been an autumn flush, so the “relief rally off the lows” mechanism has less to work with. Detrick’s comment that the historical Q4 pattern should not be viewed in isolation applies here, especially with yields at 5.3% and oil above $100.
Overall, the seasonal tailwind for October 2026 is real but should be discounted. The usual setup (a washed-out market heading into the vote) is missing. The more likely route to a large Q4 might be a further pullback in October, followed by the post-election rally, rather than a straight run higher from here.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: Downtrend
$RSP: Uptrend
$DIA: Uptrend
$IWM: No trend
$BTC: Downtrend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Uptrend
$USO: Uptrend
$TNX: Downtrend
$GLD: Downtrend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors Friday:
$HACK +4.16%
$XLE +2.60%
2%- sectors Friday:
$JETS -2.50%
$IYT -2.12%
Main sectors monthly trailing:
Leading – $XLE $XLU
Lagging – $XLI $XLK
Sub sectors monthly trailing:
Leading – $RTH $HACK
Lagging – $TAN $SMH
Bitcoin: 80k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Oil Shock & Energy Supercycle (Hormuz Supply Squeeze)
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
Exxon Mobil Corporation
Energy / Integrated Oil & Gas
refresh
refresh
All-time high 23 Oct; Q3 earnings Fri 30 Oct
refresh
CVX
Chevron Corporation
Energy / Integrated Oil & Gas
$430.2B (15 Oct)
+45.5% (15 Oct)
All-time high 23 Oct; Q3 earnings Fri 30 Oct
refresh
COP
ConocoPhillips
Energy / E&P
$170.3B (15 Oct)
+53.7% (15 Oct)
All-time high 23 Oct; Q3 earnings ~5 Nov
refresh
EOG
EOG Resources, Inc.
Energy / E&P
refresh
refresh
Leading S&P energy gainer on oil above $100; Q3 early Nov
refresh
OXY
Occidental Petroleum Corporation
Energy / E&P
refresh
refresh
High oil beta; named among Friday’s sector leaders
refresh
DVN
Devon Energy Corporation
Energy / E&P
refresh
refresh
Up >4% Friday; Q3 early Nov
refresh
FANG
Diamondback Energy, Inc.
Energy / E&P (Permian)
refresh
refresh
Up 3%+ on 16 Oct oil breakout; Q3 early Nov
refresh
APA
APA Corporation
Energy / E&P
refresh
refresh
Up >4% Friday; high-beta crude exposure
refresh
EQT
EQT Corporation
Energy / Natural Gas E&P
refresh
refresh
Gas and LNG pull-through from the Middle East disruption
Record non-Q4 bookings; ~59x forward P/E, cheaper than peers
refresh
S
SentinelOne, Inc.
Tech / Endpoint Security
refresh
refresh
Lower-valuation endpoint alternative
refresh
RBRK
Rubrik, Inc.
Tech / Data Security
refresh
refresh
Cyber-resilience growth story
refresh
CHKP
Check Point Software Technologies Ltd.
Tech / Network Security
refresh
refresh
Q3 earnings expected late Oct (confirm)
refresh
NTSK
Netskope, Inc.
Tech / SASE
refresh
refresh
+9.37% Friday; among the day’s leaders
refresh
SAIL
SailPoint, Inc.
Tech / Identity Governance
refresh
refresh
Identity spend tailwind
refresh
TENB
Tenable Holdings, Inc.
Tech / Exposure Management
refresh
refresh
Q3 earnings expected late Oct/early Nov (confirm)
refresh
QLYS
Qualys, Inc.
Tech / Vulnerability Management
refresh
refresh
Q3 earnings expected early Nov (confirm)
refresh
VRNS
Varonis Systems, Inc.
Tech / Data Security
refresh
refresh
Q3 earnings expected late Oct (confirm)
refresh
RPD
Rapid7, Inc.
Tech / Security Operations
refresh
refresh
Laggard catch-up candidate; Q3 early Nov
refresh
ETF
First Trust NASDAQ Cybersecurity ETF (CIBR)
Cyber ETF
—
~+51%
+7.4% last week
—
ETF
Global X Cybersecurity ETF (BUG)
Cyber ETF
—
refresh
Pure-play basket
—
ETF
iShares Expanded Tech-Software ETF (IGV)
Software ETF
—
refresh
+6.0% last week
—
What type of market are we in: Choppy
Key things for this week: Busy earnings week – This is the heaviest week of the season. The Fed decision, Q3 GDP and the PCE inflation data all land on the same two days as Microsoft, Alphabet and Amazon. 542 companies worth $2bn or more report this week, with Thursday the busiest day at 202 reports. Alphabet, Microsoft and Amazon are worth $10.9 trillion together, about a third of the $31.9 trillion reporting this week. The backdrop is already fragile: last week’s headlines featured stocks hit as AI growth concerns weigh on sentiment.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, $QQQ $SPY are in downtrends, expect breakouts to fail.
Are breakdowns likely to work for the next 3 – 5 days: Selectively
Should I be trading: SIPs, WSS or 5m RO on the short side.
Todays watchlist (stocks setting up): None at the moment
Yesterdays market: Money leaving the market – Very high selling pressure
TC2000 McClellan: 75
Stocks above 40PMA T2108: 41
VIX: 19
52 week highs (US common stocks): 233
Seasonality:The historical case: October is the midterm year’s best month
Since 1950, October has been the best-performing month in U.S. midterm years, averaging a 3% gain for the S&P 500 and posting positive returns 73.7% of the time. November ranks second, averaging a 2.7% gain, with positive returns 78.9% of the time. The midterm effect is large. Across all years, October has been positive nearly 60% of the time since 1950, with an average gain of 0.89%, so the midterm version roughly triples the typical October return. LPL also notes that the improvement from October onwards in midterm years has not depended on which party holds the Presidency.
The key difference from the template.
The midterm Q4 rally has historically started from a deep autumn low, which you’ve already noted. Since 1950, the S&P 500 has suffered an average peak-to-trough decline of about 18% in midterm years. In 2026, the S&P 500 fell 5% in the first quarter, rallied 15% in the second, and gained 2% in the third, and it remains less than 2% below its last record close. The early-year weakness fits the pattern. But there hasn’t been an autumn flush, so the “relief rally off the lows” mechanism has less to work with. Detrick’s comment that the historical Q4 pattern should not be viewed in isolation applies here, especially with yields at 5.3% and oil above $100.
Overall, the seasonal tailwind for October 2026 is real but should be discounted. The usual setup (a washed-out market heading into the vote) is missing. The more likely route to a large Q4 might be a further pullback in October, followed by the post-election rally, rather than a straight run higher from here.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: No trend
$RSP: Uptrend
$DIA: Uptrend
$IWM: No trend
$BTC: No trend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Uptrend
$USO: Uptrend
$TNX: Downtrend
$GLD: No trend
$SLV: Downtrend
$SLX: No trend
2%+ sectors yesterday:
$XLP +3.31%
$KRE +2.53%
$IYT +2.45%
$XLU +2.07%
2%- sectors yesterday:
$SMH -5.99%
$XLK -3.29%
$TAN -2.84%
$XTL -2.64%
Main sectors monthly trailing:
Leading – $XLE $XLP
Lagging – $XLI $XLK
Sub sectors monthly trailing:
Leading – $RTH $IYT
Lagging – $TAN $SMH
Bitcoin: 82k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Oil Shock & Energy Supercycle (Hormuz Supply Squeeze)
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
ExxonMobil Holdings Corporation
Energy / Integrated Oil & Gas
$736B
n/v
Q3 earnings 30 Oct; $4.5B refining tailwind
Moderate Buy; avg PT $175 (MS PT $185)
CVX
Chevron Corporation
Energy / Integrated Oil & Gas
$440B
n/v
Q3 earnings 30 Oct; near 52-week high
Buy; avg PT $228 (MS PT $226)
COP
ConocoPhillips
Energy / E&P
$173B
n/v
Q3 earnings 5 Nov; target raises
Buy; MS $159, Barclays $150, Wells $189
FANG
Diamondback Energy, Inc.
Energy / E&P (Permian)
$55.7B
n/v
Scotiabank initiated Outperform; Q3 earnings 2 Nov
Overweight; mean PT mid-$230s
EOG
EOG Resources, Inc.
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
OXY
Occidental Petroleum Corporation
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
MPC
Marathon Petroleum Corporation
Energy / Refining
~€122B
n/v
Diesel tightness; Wells PT $400→$560; earnings 3 Nov
Mixed; avg PT $418 (below price)
VLO
Valero Energy Corporation
Energy / Refining
n/v
n/v
Refiners expected to beat record Q2
n/v
PSX
Phillips 66
Energy / Refining
n/v
n/v
Diesel crack spreads
n/v
FRO
Frontline plc
Energy / Crude Tankers (VLCC)
~$13.2B
+158% (to 8 Oct)
Record VLCC spot rates
n/v
DHT
DHT Holdings, Inc.
Energy / Crude Tankers (VLCC)
~$3.8B
+104% (to 8 Oct)
Pure VLCC spot exposure
n/v
INSW
International Seaways, Inc.
Energy / Crude & Product Tankers
$5.6B
~+139%
Buying Bruton (4 VLCCs); earnings 5 Nov
Buy; avg PT $120 (B. Riley $140)
STNG
Scorpio Tankers Inc.
Energy / Product Tankers
$4.1B
~+63%
Earnings 29 Oct; MS PT $76→$90
Hold; avg PT $92–100
TNK
Teekay Tankers Ltd.
Energy / Crude Tankers
~$3.5–3.7B
n/v
Earnings 4 Nov
Hold; avg PT $77 (below price)
TRMD
TORM plc
Energy / Product Tankers
n/v
n/v
Hit 52-week high on product tanker rates
n/v
XLE
Energy Select Sector SPDR ETF
ETF – Energy
—
~+50%
All-time high this week
—
XOP
SPDR S&P Oil & Gas E&P ETF
ETF – E&P
—
n/v
Equal-weight producer exposure
—
BWET
Breakwave Tanker Shipping ETF
ETF – Freight futures
—
n/v
Tracks tanker freight rates
—
OIH
VanEck Oil Services ETF
ETF – Oilfield services
—
n/v
Capex follow-through
—
Theme 2: Defensive Rotation – Healthcare & Big Pharma Breakout
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Healthcare / Pharma (GLP-1)
~$1.1T
n/v
Q3 earnings 29 Oct; RBC expects beat and raise
Buy; avg PT $1,339 (Cantor $1,440)
JNJ
Johnson & Johnson
Healthcare / Pharma & MedTech
n/v
n/v
Q3 beat (EPS $2.59, revenue $25.4B)
n/v
ABBV
AbbVie Inc.
Healthcare / Pharma (Immunology)
$501B
n/v
Record high; Q3 earnings 30 Oct
Buy; avg PT $283 (Scotiabank $320)
MRK
Merck & Co., Inc.
Healthcare / Pharma
n/v
+38% (to 9 Oct)
Q3 earnings; sector momentum
Street PT ~$156 (Cantor Neutral $145)
UNH
UnitedHealth Group Incorporated
Healthcare / Managed Care
n/v
n/v
Q3 beat; 2026 EPS guide ≥$20.50; +9% on the week
Buy; avg PT ~$481
AMGN
Amgen Inc.
Healthcare / Biotech
$230B
n/v
RBC PT $400→$430
Mixed; RBC Outperform, Guggenheim Neutral $378
GILD
Gilead Sciences, Inc.
Healthcare / Biotech
n/v
n/v
Rose with the rotation
n/v
BMY
Bristol-Myers Squibb Company
Healthcare / Pharma
$122B
n/v
Q3 earnings 29 Oct; Phase 3 readouts
Hold; avg PT ~$65
PFE
Pfizer Inc.
Healthcare / Pharma
n/v
n/v
Cantor raised PT (Neutral); value play
n/v
MRNA
Moderna, Inc.
Healthcare / Biotech (mRNA)
n/v
~+177% (reported)
Personalised cancer vaccine; Goldman PT $137
Mixed; still loss-making
TMO
Thermo Fisher Scientific Inc.
Healthcare / Life-Science Tools
n/v
n/v
Q3 earnings
n/v
ABT
Abbott Laboratories
Healthcare / MedTech
n/v
n/v
Defensive MedTech; Q3 earnings
n/v
CVS
CVS Health Corporation
Healthcare / Managed Care & Pharmacy
n/v
n/v
Managed care lift after UNH beat
n/v
ICLR
ICON plc
Healthcare / CRO
n/v
n/v
Deutsche Bank sees bookings upside
n/v
FTRE
Fortrea Holdings Inc.
Healthcare / CRO
n/v
n/v
Upgraded to Buy at Deutsche Bank
Buy (DB)
XLV
Health Care Select Sector SPDR ETF
ETF – Healthcare
—
+15.9%
Record high ~$177
—
IHE
iShares US Pharmaceuticals ETF
ETF – Pharma
—
n/v
Pure pharma exposure
—
XBI
SPDR S&P Biotech ETF
ETF – Biotech
—
n/v
Higher beta; benefits from M&A
—
IHF
iShares US Healthcare Providers ETF
ETF – Managed Care
—
n/v
UNH/CVS recovery
—
What type of market are we in: Weak with lots of rotation
Key things for this week: Big tech earnings
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, good earnings are getting sold.
Are breakdowns likely to work for the next 3 – 5 days: Selectively
Catalyst / setup – Leading sector with lots of eyes on it, big gap down was expecting dip buyers at the market open, bought on break above 10 sma with MACD on 5 min chart (Front ran the MACD signal as hadn’t quite crossed when I entered but did cross shortly after)
Result – Scaled 50% at 91.75 after 1% move @ 14:55, scaled another 50% at 92.86 after 2% move @ 14:57, runner stopped at 89 @ 15:22.
Yesterdays market: Money entering the market – Normal buying pressure
TC2000 McClellan: 55
Stocks above 40PMA T2108: 36
VIX: 17
52 week highs (US common stocks): 208
Seasonality:The historical case: October is the midterm year’s best month
Since 1950, October has been the best-performing month in U.S. midterm years, averaging a 3% gain for the S&P 500 and posting positive returns 73.7% of the time. November ranks second, averaging a 2.7% gain, with positive returns 78.9% of the time. The midterm effect is large. Across all years, October has been positive nearly 60% of the time since 1950, with an average gain of 0.89%, so the midterm version roughly triples the typical October return. LPL also notes that the improvement from October onwards in midterm years has not depended on which party holds the Presidency.
The key difference from the template.
The midterm Q4 rally has historically started from a deep autumn low, which you’ve already noted. Since 1950, the S&P 500 has suffered an average peak-to-trough decline of about 18% in midterm years. In 2026, the S&P 500 fell 5% in the first quarter, rallied 15% in the second, and gained 2% in the third, and it remains less than 2% below its last record close. The early-year weakness fits the pattern. But there hasn’t been an autumn flush, so the “relief rally off the lows” mechanism has less to work with. Detrick’s comment that the historical Q4 pattern should not be viewed in isolation applies here, especially with yields at 5.3% and oil above $100.
Overall, the seasonal tailwind for October 2026 is real but should be discounted. The usual setup (a washed-out market heading into the vote) is missing. The more likely route to a large Q4 might be a further pullback in October, followed by the post-election rally, rather than a straight run higher from here.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: No trend
$RSP: Uptrend
$DIA: Uptrend
$IWM: No trend
$BTC: No trend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Uptrend
$USO: Uptrend
$TNX: Downtrend
$GLD: No trend
$SLV: Downtrend
$SLX: No trend
2%+ sectors yesterday:
$HACK +3.24%
2%- sectors yesterday:
None
Main sectors monthly trailing:
Leading – $XLE $XLP
Lagging – $XLI $XLK
Sub sectors monthly trailing:
Leading – $RTH $IGV
Lagging – $TAN $JETS
Bitcoin: 82k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Oil Shock & Energy Supercycle (Hormuz Supply Squeeze)
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
ExxonMobil Holdings Corporation
Energy / Integrated Oil & Gas
$736B
n/v
Q3 earnings 30 Oct; $4.5B refining tailwind
Moderate Buy; avg PT $175 (MS PT $185)
CVX
Chevron Corporation
Energy / Integrated Oil & Gas
$440B
n/v
Q3 earnings 30 Oct; near 52-week high
Buy; avg PT $228 (MS PT $226)
COP
ConocoPhillips
Energy / E&P
$173B
n/v
Q3 earnings 5 Nov; target raises
Buy; MS $159, Barclays $150, Wells $189
FANG
Diamondback Energy, Inc.
Energy / E&P (Permian)
$55.7B
n/v
Scotiabank initiated Outperform; Q3 earnings 2 Nov
Overweight; mean PT mid-$230s
EOG
EOG Resources, Inc.
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
OXY
Occidental Petroleum Corporation
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
MPC
Marathon Petroleum Corporation
Energy / Refining
~€122B
n/v
Diesel tightness; Wells PT $400→$560; earnings 3 Nov
Mixed; avg PT $418 (below price)
VLO
Valero Energy Corporation
Energy / Refining
n/v
n/v
Refiners expected to beat record Q2
n/v
PSX
Phillips 66
Energy / Refining
n/v
n/v
Diesel crack spreads
n/v
FRO
Frontline plc
Energy / Crude Tankers (VLCC)
~$13.2B
+158% (to 8 Oct)
Record VLCC spot rates
n/v
DHT
DHT Holdings, Inc.
Energy / Crude Tankers (VLCC)
~$3.8B
+104% (to 8 Oct)
Pure VLCC spot exposure
n/v
INSW
International Seaways, Inc.
Energy / Crude & Product Tankers
$5.6B
~+139%
Buying Bruton (4 VLCCs); earnings 5 Nov
Buy; avg PT $120 (B. Riley $140)
STNG
Scorpio Tankers Inc.
Energy / Product Tankers
$4.1B
~+63%
Earnings 29 Oct; MS PT $76→$90
Hold; avg PT $92–100
TNK
Teekay Tankers Ltd.
Energy / Crude Tankers
~$3.5–3.7B
n/v
Earnings 4 Nov
Hold; avg PT $77 (below price)
TRMD
TORM plc
Energy / Product Tankers
n/v
n/v
Hit 52-week high on product tanker rates
n/v
XLE
Energy Select Sector SPDR ETF
ETF – Energy
—
~+50%
All-time high this week
—
XOP
SPDR S&P Oil & Gas E&P ETF
ETF – E&P
—
n/v
Equal-weight producer exposure
—
BWET
Breakwave Tanker Shipping ETF
ETF – Freight futures
—
n/v
Tracks tanker freight rates
—
OIH
VanEck Oil Services ETF
ETF – Oilfield services
—
n/v
Capex follow-through
—
Theme 2: Defensive Rotation – Healthcare & Big Pharma Breakout
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Healthcare / Pharma (GLP-1)
~$1.1T
n/v
Q3 earnings 29 Oct; RBC expects beat and raise
Buy; avg PT $1,339 (Cantor $1,440)
JNJ
Johnson & Johnson
Healthcare / Pharma & MedTech
n/v
n/v
Q3 beat (EPS $2.59, revenue $25.4B)
n/v
ABBV
AbbVie Inc.
Healthcare / Pharma (Immunology)
$501B
n/v
Record high; Q3 earnings 30 Oct
Buy; avg PT $283 (Scotiabank $320)
MRK
Merck & Co., Inc.
Healthcare / Pharma
n/v
+38% (to 9 Oct)
Q3 earnings; sector momentum
Street PT ~$156 (Cantor Neutral $145)
UNH
UnitedHealth Group Incorporated
Healthcare / Managed Care
n/v
n/v
Q3 beat; 2026 EPS guide ≥$20.50; +9% on the week
Buy; avg PT ~$481
AMGN
Amgen Inc.
Healthcare / Biotech
$230B
n/v
RBC PT $400→$430
Mixed; RBC Outperform, Guggenheim Neutral $378
GILD
Gilead Sciences, Inc.
Healthcare / Biotech
n/v
n/v
Rose with the rotation
n/v
BMY
Bristol-Myers Squibb Company
Healthcare / Pharma
$122B
n/v
Q3 earnings 29 Oct; Phase 3 readouts
Hold; avg PT ~$65
PFE
Pfizer Inc.
Healthcare / Pharma
n/v
n/v
Cantor raised PT (Neutral); value play
n/v
MRNA
Moderna, Inc.
Healthcare / Biotech (mRNA)
n/v
~+177% (reported)
Personalised cancer vaccine; Goldman PT $137
Mixed; still loss-making
TMO
Thermo Fisher Scientific Inc.
Healthcare / Life-Science Tools
n/v
n/v
Q3 earnings
n/v
ABT
Abbott Laboratories
Healthcare / MedTech
n/v
n/v
Defensive MedTech; Q3 earnings
n/v
CVS
CVS Health Corporation
Healthcare / Managed Care & Pharmacy
n/v
n/v
Managed care lift after UNH beat
n/v
ICLR
ICON plc
Healthcare / CRO
n/v
n/v
Deutsche Bank sees bookings upside
n/v
FTRE
Fortrea Holdings Inc.
Healthcare / CRO
n/v
n/v
Upgraded to Buy at Deutsche Bank
Buy (DB)
XLV
Health Care Select Sector SPDR ETF
ETF – Healthcare
—
+15.9%
Record high ~$177
—
IHE
iShares US Pharmaceuticals ETF
ETF – Pharma
—
n/v
Pure pharma exposure
—
XBI
SPDR S&P Biotech ETF
ETF – Biotech
—
n/v
Higher beta; benefits from M&A
—
IHF
iShares US Healthcare Providers ETF
ETF – Managed Care
—
n/v
UNH/CVS recovery
—
What type of market are we in: Weak
Key things for this week: Big tech earnings
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, markets just chopping around in a weak environment, good earnings typically not being rewarded.
Are breakdowns likely to work for the next 3 – 5 days: Selectively
Should I be trading: SIPs, don’t expect multi day moves to hold. Lots of tech charts seem to be trying to put a bottom in but futures look like a big gap down pre market.
Todays watchlist (stocks setting up): Symbols from TC2000 SOXL TQQQ
Yesterdays market: Money entering the market – High buying pressure
TC2000 McClellan: 58
Stocks above 40PMA T2108: 35
VIX: 17
52 week highs (US common stocks): 201
Seasonality:The historical case: October is the midterm year’s best month
Since 1950, October has been the best-performing month in U.S. midterm years, averaging a 3% gain for the S&P 500 and posting positive returns 73.7% of the time. November ranks second, averaging a 2.7% gain, with positive returns 78.9% of the time. The midterm effect is large. Across all years, October has been positive nearly 60% of the time since 1950, with an average gain of 0.89%, so the midterm version roughly triples the typical October return. LPL also notes that the improvement from October onwards in midterm years has not depended on which party holds the Presidency.
The key difference from the template.
The midterm Q4 rally has historically started from a deep autumn low, which you’ve already noted. Since 1950, the S&P 500 has suffered an average peak-to-trough decline of about 18% in midterm years. In 2026, the S&P 500 fell 5% in the first quarter, rallied 15% in the second, and gained 2% in the third, and it remains less than 2% below its last record close. The early-year weakness fits the pattern. But there hasn’t been an autumn flush, so the “relief rally off the lows” mechanism has less to work with. Detrick’s comment that the historical Q4 pattern should not be viewed in isolation applies here, especially with yields at 5.3% and oil above $100.
Overall, the seasonal tailwind for October 2026 is real but should be discounted. The usual setup (a washed-out market heading into the vote) is missing. The more likely route to a large Q4 might be a further pullback in October, followed by the post-election rally, rather than a straight run higher from here.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: Downtrend
$RSP: Uptrend
$DIA: Uptrend
$IWM: No trend
$BTC: Uptrend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Uptrend
$USO: Uptrend
$TNX: Downtrend
$GLD: No trend
$SLV: Downtrend
$SLX: No trend
2%+ sectors yesterday:
$IBB +3.16%
$JETS +2.38%
$XLV +2.37%
2%- sectors yesterday:
None
Main sectors monthly trailing:
Leading – $XLV $XLP
Lagging – $XLI $XLK
Sub sectors monthly trailing:
Leading – $RTH $IGV
Lagging – $TAN $JETS
Bitcoin: 82k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Oil Shock & Energy Supercycle (Hormuz Supply Squeeze)
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
ExxonMobil Holdings Corporation
Energy / Integrated Oil & Gas
$736B
n/v
Q3 earnings 30 Oct; $4.5B refining tailwind
Moderate Buy; avg PT $175 (MS PT $185)
CVX
Chevron Corporation
Energy / Integrated Oil & Gas
$440B
n/v
Q3 earnings 30 Oct; near 52-week high
Buy; avg PT $228 (MS PT $226)
COP
ConocoPhillips
Energy / E&P
$173B
n/v
Q3 earnings 5 Nov; target raises
Buy; MS $159, Barclays $150, Wells $189
FANG
Diamondback Energy, Inc.
Energy / E&P (Permian)
$55.7B
n/v
Scotiabank initiated Outperform; Q3 earnings 2 Nov
Overweight; mean PT mid-$230s
EOG
EOG Resources, Inc.
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
OXY
Occidental Petroleum Corporation
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
MPC
Marathon Petroleum Corporation
Energy / Refining
~€122B
n/v
Diesel tightness; Wells PT $400→$560; earnings 3 Nov
Mixed; avg PT $418 (below price)
VLO
Valero Energy Corporation
Energy / Refining
n/v
n/v
Refiners expected to beat record Q2
n/v
PSX
Phillips 66
Energy / Refining
n/v
n/v
Diesel crack spreads
n/v
FRO
Frontline plc
Energy / Crude Tankers (VLCC)
~$13.2B
+158% (to 8 Oct)
Record VLCC spot rates
n/v
DHT
DHT Holdings, Inc.
Energy / Crude Tankers (VLCC)
~$3.8B
+104% (to 8 Oct)
Pure VLCC spot exposure
n/v
INSW
International Seaways, Inc.
Energy / Crude & Product Tankers
$5.6B
~+139%
Buying Bruton (4 VLCCs); earnings 5 Nov
Buy; avg PT $120 (B. Riley $140)
STNG
Scorpio Tankers Inc.
Energy / Product Tankers
$4.1B
~+63%
Earnings 29 Oct; MS PT $76→$90
Hold; avg PT $92–100
TNK
Teekay Tankers Ltd.
Energy / Crude Tankers
~$3.5–3.7B
n/v
Earnings 4 Nov
Hold; avg PT $77 (below price)
TRMD
TORM plc
Energy / Product Tankers
n/v
n/v
Hit 52-week high on product tanker rates
n/v
XLE
Energy Select Sector SPDR ETF
ETF – Energy
—
~+50%
All-time high this week
—
XOP
SPDR S&P Oil & Gas E&P ETF
ETF – E&P
—
n/v
Equal-weight producer exposure
—
BWET
Breakwave Tanker Shipping ETF
ETF – Freight futures
—
n/v
Tracks tanker freight rates
—
OIH
VanEck Oil Services ETF
ETF – Oilfield services
—
n/v
Capex follow-through
—
Theme 2: Defensive Rotation – Healthcare & Big Pharma Breakout
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Healthcare / Pharma (GLP-1)
~$1.1T
n/v
Q3 earnings 29 Oct; RBC expects beat and raise
Buy; avg PT $1,339 (Cantor $1,440)
JNJ
Johnson & Johnson
Healthcare / Pharma & MedTech
n/v
n/v
Q3 beat (EPS $2.59, revenue $25.4B)
n/v
ABBV
AbbVie Inc.
Healthcare / Pharma (Immunology)
$501B
n/v
Record high; Q3 earnings 30 Oct
Buy; avg PT $283 (Scotiabank $320)
MRK
Merck & Co., Inc.
Healthcare / Pharma
n/v
+38% (to 9 Oct)
Q3 earnings; sector momentum
Street PT ~$156 (Cantor Neutral $145)
UNH
UnitedHealth Group Incorporated
Healthcare / Managed Care
n/v
n/v
Q3 beat; 2026 EPS guide ≥$20.50; +9% on the week
Buy; avg PT ~$481
AMGN
Amgen Inc.
Healthcare / Biotech
$230B
n/v
RBC PT $400→$430
Mixed; RBC Outperform, Guggenheim Neutral $378
GILD
Gilead Sciences, Inc.
Healthcare / Biotech
n/v
n/v
Rose with the rotation
n/v
BMY
Bristol-Myers Squibb Company
Healthcare / Pharma
$122B
n/v
Q3 earnings 29 Oct; Phase 3 readouts
Hold; avg PT ~$65
PFE
Pfizer Inc.
Healthcare / Pharma
n/v
n/v
Cantor raised PT (Neutral); value play
n/v
MRNA
Moderna, Inc.
Healthcare / Biotech (mRNA)
n/v
~+177% (reported)
Personalised cancer vaccine; Goldman PT $137
Mixed; still loss-making
TMO
Thermo Fisher Scientific Inc.
Healthcare / Life-Science Tools
n/v
n/v
Q3 earnings
n/v
ABT
Abbott Laboratories
Healthcare / MedTech
n/v
n/v
Defensive MedTech; Q3 earnings
n/v
CVS
CVS Health Corporation
Healthcare / Managed Care & Pharmacy
n/v
n/v
Managed care lift after UNH beat
n/v
ICLR
ICON plc
Healthcare / CRO
n/v
n/v
Deutsche Bank sees bookings upside
n/v
FTRE
Fortrea Holdings Inc.
Healthcare / CRO
n/v
n/v
Upgraded to Buy at Deutsche Bank
Buy (DB)
XLV
Health Care Select Sector SPDR ETF
ETF – Healthcare
—
+15.9%
Record high ~$177
—
IHE
iShares US Pharmaceuticals ETF
ETF – Pharma
—
n/v
Pure pharma exposure
—
XBI
SPDR S&P Biotech ETF
ETF – Biotech
—
n/v
Higher beta; benefits from M&A
—
IHF
iShares US Healthcare Providers ETF
ETF – Managed Care
—
n/v
UNH/CVS recovery
—
What type of market are we in: Weak
Key things for this week: Big earnings include $META, $TSLA, $NFLX, $GM and $PG. Chips remain weak: they fell for an eighth straight day, and the Nasdaq 100 lost 5.5% on the week
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, markets just chopping around in a weak environment, good earnings typically not being rewarded so far.
Are breakdowns likely to work for the next 3 – 5 days: Selectively
Should I be trading: SIPs, don’t expect multi day moves to hold. Tech tried to rally yesterday but gave most back intrday.
Todays watchlist (stocks setting up): Symbols from TC2000 SOXL TQQQ
Yesterdays market: Money leaving the market – Normal selling pressure
TC2000 McClellan: 10
Stocks above 40PMA T2108: 29
VIX: 18
52 week highs (US common stocks): 156
Seasonality:The historical case: October is the midterm year’s best month
Since 1950, October has been the best-performing month in U.S. midterm years, averaging a 3% gain for the S&P 500 and posting positive returns 73.7% of the time. November ranks second, averaging a 2.7% gain, with positive returns 78.9% of the time. The midterm effect is large. Across all years, October has been positive nearly 60% of the time since 1950, with an average gain of 0.89%, so the midterm version roughly triples the typical October return. LPL also notes that the improvement from October onwards in midterm years has not depended on which party holds the Presidency.
The key difference from the template.
The midterm Q4 rally has historically started from a deep autumn low, which you’ve already noted. Since 1950, the S&P 500 has suffered an average peak-to-trough decline of about 18% in midterm years. In 2026, the S&P 500 fell 5% in the first quarter, rallied 15% in the second, and gained 2% in the third, and it remains less than 2% below its last record close. The early-year weakness fits the pattern. But there hasn’t been an autumn flush, so the “relief rally off the lows” mechanism has less to work with. Detrick’s comment that the historical Q4 pattern should not be viewed in isolation applies here, especially with yields at 5.3% and oil above $100.
Overall, the seasonal tailwind for October 2026 is real but should be discounted. The usual setup (a washed-out market heading into the vote) is missing. The more likely route to a large Q4 might be a further pullback in October, followed by the post-election rally, rather than a straight run higher from here.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: Downtrend
$RSP: Uptrend
$DIA: Uptrend
$IWM: Downtrend
$BTC: Downtrend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Uptrend
$USO: Uptrend
$TNX: Downtrend
$GLD: No trend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors yesterday:
None
2%- sectors yesterday:
$XLU -2.01%
Main sectors monthly trailing:
Leading – $XLE $XLP
Lagging – $XLF $IBB
Sub sectors monthly trailing:
Leading – $RTH $IGV
Lagging – $TAN $JETS
Bitcoin: 82k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Oil Shock & Energy Supercycle (Hormuz Supply Squeeze)
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
ExxonMobil Holdings Corporation
Energy / Integrated Oil & Gas
$736B
n/v
Q3 earnings 30 Oct; $4.5B refining tailwind
Moderate Buy; avg PT $175 (MS PT $185)
CVX
Chevron Corporation
Energy / Integrated Oil & Gas
$440B
n/v
Q3 earnings 30 Oct; near 52-week high
Buy; avg PT $228 (MS PT $226)
COP
ConocoPhillips
Energy / E&P
$173B
n/v
Q3 earnings 5 Nov; target raises
Buy; MS $159, Barclays $150, Wells $189
FANG
Diamondback Energy, Inc.
Energy / E&P (Permian)
$55.7B
n/v
Scotiabank initiated Outperform; Q3 earnings 2 Nov
Overweight; mean PT mid-$230s
EOG
EOG Resources, Inc.
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
OXY
Occidental Petroleum Corporation
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
MPC
Marathon Petroleum Corporation
Energy / Refining
~€122B
n/v
Diesel tightness; Wells PT $400→$560; earnings 3 Nov
Mixed; avg PT $418 (below price)
VLO
Valero Energy Corporation
Energy / Refining
n/v
n/v
Refiners expected to beat record Q2
n/v
PSX
Phillips 66
Energy / Refining
n/v
n/v
Diesel crack spreads
n/v
FRO
Frontline plc
Energy / Crude Tankers (VLCC)
~$13.2B
+158% (to 8 Oct)
Record VLCC spot rates
n/v
DHT
DHT Holdings, Inc.
Energy / Crude Tankers (VLCC)
~$3.8B
+104% (to 8 Oct)
Pure VLCC spot exposure
n/v
INSW
International Seaways, Inc.
Energy / Crude & Product Tankers
$5.6B
~+139%
Buying Bruton (4 VLCCs); earnings 5 Nov
Buy; avg PT $120 (B. Riley $140)
STNG
Scorpio Tankers Inc.
Energy / Product Tankers
$4.1B
~+63%
Earnings 29 Oct; MS PT $76→$90
Hold; avg PT $92–100
TNK
Teekay Tankers Ltd.
Energy / Crude Tankers
~$3.5–3.7B
n/v
Earnings 4 Nov
Hold; avg PT $77 (below price)
TRMD
TORM plc
Energy / Product Tankers
n/v
n/v
Hit 52-week high on product tanker rates
n/v
XLE
Energy Select Sector SPDR ETF
ETF – Energy
—
~+50%
All-time high this week
—
XOP
SPDR S&P Oil & Gas E&P ETF
ETF – E&P
—
n/v
Equal-weight producer exposure
—
BWET
Breakwave Tanker Shipping ETF
ETF – Freight futures
—
n/v
Tracks tanker freight rates
—
OIH
VanEck Oil Services ETF
ETF – Oilfield services
—
n/v
Capex follow-through
—
Theme 2: Defensive Rotation – Healthcare & Big Pharma Breakout
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Healthcare / Pharma (GLP-1)
~$1.1T
n/v
Q3 earnings 29 Oct; RBC expects beat and raise
Buy; avg PT $1,339 (Cantor $1,440)
JNJ
Johnson & Johnson
Healthcare / Pharma & MedTech
n/v
n/v
Q3 beat (EPS $2.59, revenue $25.4B)
n/v
ABBV
AbbVie Inc.
Healthcare / Pharma (Immunology)
$501B
n/v
Record high; Q3 earnings 30 Oct
Buy; avg PT $283 (Scotiabank $320)
MRK
Merck & Co., Inc.
Healthcare / Pharma
n/v
+38% (to 9 Oct)
Q3 earnings; sector momentum
Street PT ~$156 (Cantor Neutral $145)
UNH
UnitedHealth Group Incorporated
Healthcare / Managed Care
n/v
n/v
Q3 beat; 2026 EPS guide ≥$20.50; +9% on the week
Buy; avg PT ~$481
AMGN
Amgen Inc.
Healthcare / Biotech
$230B
n/v
RBC PT $400→$430
Mixed; RBC Outperform, Guggenheim Neutral $378
GILD
Gilead Sciences, Inc.
Healthcare / Biotech
n/v
n/v
Rose with the rotation
n/v
BMY
Bristol-Myers Squibb Company
Healthcare / Pharma
$122B
n/v
Q3 earnings 29 Oct; Phase 3 readouts
Hold; avg PT ~$65
PFE
Pfizer Inc.
Healthcare / Pharma
n/v
n/v
Cantor raised PT (Neutral); value play
n/v
MRNA
Moderna, Inc.
Healthcare / Biotech (mRNA)
n/v
~+177% (reported)
Personalised cancer vaccine; Goldman PT $137
Mixed; still loss-making
TMO
Thermo Fisher Scientific Inc.
Healthcare / Life-Science Tools
n/v
n/v
Q3 earnings
n/v
ABT
Abbott Laboratories
Healthcare / MedTech
n/v
n/v
Defensive MedTech; Q3 earnings
n/v
CVS
CVS Health Corporation
Healthcare / Managed Care & Pharmacy
n/v
n/v
Managed care lift after UNH beat
n/v
ICLR
ICON plc
Healthcare / CRO
n/v
n/v
Deutsche Bank sees bookings upside
n/v
FTRE
Fortrea Holdings Inc.
Healthcare / CRO
n/v
n/v
Upgraded to Buy at Deutsche Bank
Buy (DB)
XLV
Health Care Select Sector SPDR ETF
ETF – Healthcare
—
+15.9%
Record high ~$177
—
IHE
iShares US Pharmaceuticals ETF
ETF – Pharma
—
n/v
Pure pharma exposure
—
XBI
SPDR S&P Biotech ETF
ETF – Biotech
—
n/v
Higher beta; benefits from M&A
—
IHF
iShares US Healthcare Providers ETF
ETF – Managed Care
—
n/v
UNH/CVS recovery
—
What type of market are we in: Weak
Key things for this week: Big earnings include $META, $TSLA, $NFLX, $GM and $PG. Chips remain weak: they fell for an eighth straight day, and the Nasdaq 100 lost 5.5% on the week
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, markets just chopping around in a weak environment
Are breakdowns likely to work for the next 3 – 5 days: Selectively, 20% study bearish in the 50’s
Should I be trading: SIPs, don’t expect multi day moves to hold. Lots of things look to be setting up short.
Fridays market: Money leaving the market – High selling pressure
TC2000 McClellan: 36
Stocks above 40PMA T2108: 30
VIX: 20
52 week highs (US common stocks): 193
Seasonality:The historical case: October is the midterm year’s best month
Since 1950, October has been the best-performing month in U.S. midterm years, averaging a 3% gain for the S&P 500 and posting positive returns 73.7% of the time. November ranks second, averaging a 2.7% gain, with positive returns 78.9% of the time. The midterm effect is large. Across all years, October has been positive nearly 60% of the time since 1950, with an average gain of 0.89%, so the midterm version roughly triples the typical October return. LPL also notes that the improvement from October onwards in midterm years has not depended on which party holds the Presidency.
The key difference from the template.
The midterm Q4 rally has historically started from a deep autumn low, which you’ve already noted. Since 1950, the S&P 500 has suffered an average peak-to-trough decline of about 18% in midterm years. In 2026, the S&P 500 fell 5% in the first quarter, rallied 15% in the second, and gained 2% in the third, and it remains less than 2% below its last record close. The early-year weakness fits the pattern. But there hasn’t been an autumn flush, so the “relief rally off the lows” mechanism has less to work with. Detrick’s comment that the historical Q4 pattern should not be viewed in isolation applies here, especially with yields at 5.3% and oil above $100.
Overall, the seasonal tailwind for October 2026 is real but should be discounted. The usual setup (a washed-out market heading into the vote) is missing. The more likely route to a large Q4 might be a further pullback in October, followed by the post-election rally, rather than a straight run higher from here.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: No trend
$RSP: Uptrend
$DIA: Uptrend
$IWM: Downtrend
$BTC: No trend
$SQQQ: Uptrend
$UVIX: No trend
$TLT: Uptrend
$USO: Uptrend
$TNX: Downtrend
$GLD: No trend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors Friday:
$XLE +2.52%
2%- sectors Friday:
$IGV -4.80%
$HACK -4.21%
$SMH -3.41%
$XLK -3.02%
$XTL -2.92%
$JETS -2.67%
$IBB -2.61%
$TAN -2.11%
Main sectors monthly trailing:
Leading – $XLE $XLV
Lagging – $XLF $XLI
Sub sectors monthly trailing:
Leading – $RTH $IYT
Lagging – $TAN $JETS
Bitcoin: 82k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Oil Shock & Energy Supercycle (Hormuz Supply Squeeze)
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
ExxonMobil Holdings Corporation
Energy / Integrated Oil & Gas
$736B
n/v
Q3 earnings 30 Oct; $4.5B refining tailwind
Moderate Buy; avg PT $175 (MS PT $185)
CVX
Chevron Corporation
Energy / Integrated Oil & Gas
$440B
n/v
Q3 earnings 30 Oct; near 52-week high
Buy; avg PT $228 (MS PT $226)
COP
ConocoPhillips
Energy / E&P
$173B
n/v
Q3 earnings 5 Nov; target raises
Buy; MS $159, Barclays $150, Wells $189
FANG
Diamondback Energy, Inc.
Energy / E&P (Permian)
$55.7B
n/v
Scotiabank initiated Outperform; Q3 earnings 2 Nov
Overweight; mean PT mid-$230s
EOG
EOG Resources, Inc.
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
OXY
Occidental Petroleum Corporation
Energy / E&P
n/v
n/v
Leverage to $100 WTI; Q3 earnings
n/v
MPC
Marathon Petroleum Corporation
Energy / Refining
~€122B
n/v
Diesel tightness; Wells PT $400→$560; earnings 3 Nov
Mixed; avg PT $418 (below price)
VLO
Valero Energy Corporation
Energy / Refining
n/v
n/v
Refiners expected to beat record Q2
n/v
PSX
Phillips 66
Energy / Refining
n/v
n/v
Diesel crack spreads
n/v
FRO
Frontline plc
Energy / Crude Tankers (VLCC)
~$13.2B
+158% (to 8 Oct)
Record VLCC spot rates
n/v
DHT
DHT Holdings, Inc.
Energy / Crude Tankers (VLCC)
~$3.8B
+104% (to 8 Oct)
Pure VLCC spot exposure
n/v
INSW
International Seaways, Inc.
Energy / Crude & Product Tankers
$5.6B
~+139%
Buying Bruton (4 VLCCs); earnings 5 Nov
Buy; avg PT $120 (B. Riley $140)
STNG
Scorpio Tankers Inc.
Energy / Product Tankers
$4.1B
~+63%
Earnings 29 Oct; MS PT $76→$90
Hold; avg PT $92–100
TNK
Teekay Tankers Ltd.
Energy / Crude Tankers
~$3.5–3.7B
n/v
Earnings 4 Nov
Hold; avg PT $77 (below price)
TRMD
TORM plc
Energy / Product Tankers
n/v
n/v
Hit 52-week high on product tanker rates
n/v
XLE
Energy Select Sector SPDR ETF
ETF – Energy
—
~+50%
All-time high this week
—
XOP
SPDR S&P Oil & Gas E&P ETF
ETF – E&P
—
n/v
Equal-weight producer exposure
—
BWET
Breakwave Tanker Shipping ETF
ETF – Freight futures
—
n/v
Tracks tanker freight rates
—
OIH
VanEck Oil Services ETF
ETF – Oilfield services
—
n/v
Capex follow-through
—
Theme 2: Defensive Rotation – Healthcare & Big Pharma Breakout
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Healthcare / Pharma (GLP-1)
~$1.1T
n/v
Q3 earnings 29 Oct; RBC expects beat and raise
Buy; avg PT $1,339 (Cantor $1,440)
JNJ
Johnson & Johnson
Healthcare / Pharma & MedTech
n/v
n/v
Q3 beat (EPS $2.59, revenue $25.4B)
n/v
ABBV
AbbVie Inc.
Healthcare / Pharma (Immunology)
$501B
n/v
Record high; Q3 earnings 30 Oct
Buy; avg PT $283 (Scotiabank $320)
MRK
Merck & Co., Inc.
Healthcare / Pharma
n/v
+38% (to 9 Oct)
Q3 earnings; sector momentum
Street PT ~$156 (Cantor Neutral $145)
UNH
UnitedHealth Group Incorporated
Healthcare / Managed Care
n/v
n/v
Q3 beat; 2026 EPS guide ≥$20.50; +9% on the week
Buy; avg PT ~$481
AMGN
Amgen Inc.
Healthcare / Biotech
$230B
n/v
RBC PT $400→$430
Mixed; RBC Outperform, Guggenheim Neutral $378
GILD
Gilead Sciences, Inc.
Healthcare / Biotech
n/v
n/v
Rose with the rotation
n/v
BMY
Bristol-Myers Squibb Company
Healthcare / Pharma
$122B
n/v
Q3 earnings 29 Oct; Phase 3 readouts
Hold; avg PT ~$65
PFE
Pfizer Inc.
Healthcare / Pharma
n/v
n/v
Cantor raised PT (Neutral); value play
n/v
MRNA
Moderna, Inc.
Healthcare / Biotech (mRNA)
n/v
~+177% (reported)
Personalised cancer vaccine; Goldman PT $137
Mixed; still loss-making
TMO
Thermo Fisher Scientific Inc.
Healthcare / Life-Science Tools
n/v
n/v
Q3 earnings
n/v
ABT
Abbott Laboratories
Healthcare / MedTech
n/v
n/v
Defensive MedTech; Q3 earnings
n/v
CVS
CVS Health Corporation
Healthcare / Managed Care & Pharmacy
n/v
n/v
Managed care lift after UNH beat
n/v
ICLR
ICON plc
Healthcare / CRO
n/v
n/v
Deutsche Bank sees bookings upside
n/v
FTRE
Fortrea Holdings Inc.
Healthcare / CRO
n/v
n/v
Upgraded to Buy at Deutsche Bank
Buy (DB)
XLV
Health Care Select Sector SPDR ETF
ETF – Healthcare
—
+15.9%
Record high ~$177
—
IHE
iShares US Pharmaceuticals ETF
ETF – Pharma
—
n/v
Pure pharma exposure
—
XBI
SPDR S&P Biotech ETF
ETF – Biotech
—
n/v
Higher beta; benefits from M&A
—
IHF
iShares US Healthcare Providers ETF
ETF – Managed Care
—
n/v
UNH/CVS recovery
—
What type of market are we in: Weak, selling off
Key things for this week: Big earnings include $META, $TSLA, $NFLX, $GM and $PG. Chips remain weak: they fell for an eighth straight day, and the Nasdaq 100 lost 5.5% on the week
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, 20% study bullish is under 10 suggesting a short term bounce is likely but not likely a market to be holding positions for multiple days.
Are breakdowns likely to work for the next 3 – 5 days: No, 20% study bearish over 100 suggesting a bounce is coming, will it be a bounce or a more sustained move.
Should I be trading: SIPs, don’t expect multi day moves to hold.
Todays watchlist (stocks setting up): Nothing at the moment
Catalyst / setup – Markets gapped down on hot CPI read, which could reduce the likelihood of interest rates. Markets initially rose and the 20% bullish study was under 10 which is a bounce zone, the zCombo was bullish so took a low risk long position on a break of the opening 5m bar.
Result – No scales, fully stopped at 16:37 @ 50.99 for full loss -100%
Catalyst / setup – Down about 20% in approx a week and gapped down approx 5.5% at the open, memory being a key theme in the AI trade naturally will have a lot of eyes on it, my Zcombo indicator was leaning bullish from the open so took a low risk entry against the lows, risking 34 cents which I saw as a good R:R for playing an oversold bounce.
Result – Runner running, scaled 50% @ 14:39 after 1% move up at 52.01, and scaled another 50% @ 17:30 after 2% move at 52.62
Update 14/10 pre market: Runner stopped pre market on CPI print at 13:35 @ 51.30, approx 100% profit overall on the trade